Guangdong VTR Bio-Tech Co Ltd
300381
Company Profile
Business description
Guangdong VTR Bio-Tech Co Ltd is a China based biotechnology company. It is engaged in the research, development, production, sales and service of biopharmaceuticals, bio-enzyme preparations, microbial preparations, functional additives and green biological manufacturing engineering. The company's products include Wittler tributyrin, temperature glucose oxidase, Mildew, VTR-TH26 glucoamylase, Sorghum specific compound enzyme and others. It sells its products in China, and also exports it to various other countries.
Contact
No. 8, Pingbei 1st Road
Nanping High-tech Industrial Zone
Guangdong Province
Zhuhai519060
CHNT: +86 7568676888
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
1,102
Stocks News & Analysis
stocks
Unwarranted drop in ASX share
Jittery investors misinterpret an audit for an existential crisis.
stocks
After earnings, is Disney stock a buy, a sell, or fairly valued? -
Following the highly anticipated announcement of a new CEO, here’s what we think of Disney.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,281.80 | 97.30 | 1.06% |
| CAC 40 | 8,342.80 | 14.92 | 0.18% |
| DAX 40 | 24,977.98 | 9.87 | -0.04% |
| Dow JONES (US) | 50,422.64 | 234.50 | 0.47% |
| FTSE 100 | 10,461.23 | 107.39 | 1.04% |
| HKSE | 27,266.38 | 83.23 | 0.31% |
| NASDAQ | 23,222.15 | 119.67 | 0.52% |
| Nikkei 225 | 57,650.54 | 1,286.60 | 2.28% |
| NZX 50 Index | 13,507.28 | 60.91 | 0.45% |
| S&P 500 | 6,977.15 | 35.34 | 0.51% |
| S&P/ASX 200 | 9,014.80 | 98.80 | 1.11% |
| SSE Composite Index | 4,131.98 | 3.61 | 0.09% |